{
  "docId": "019de074-0cc8-70d5-8924-3a1b552a09af",
  "docSlug": "77b0d3b8437e31981ed49d98afb5005f",
  "documentTitle": "OmniAb | Investor Conference Presentation Deck | 43 slides",
  "authorId": "omniab",
  "authorName": "OmniAb",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 40,
  "pageCount": 43,
  "prevPage": 39,
  "nextPage": 41,
  "slideType": "key_messages",
  "function": "summarize",
  "density": "overcrowded",
  "nDataPoints": 2,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-0cc8-70d5-8924-3a1b552a09af/40",
  "deckHref": "/decks/019de074-0cc8-70d5-8924-3a1b552a09af",
  "deckJsonHref": "/decks/019de074-0cc8-70d5-8924-3a1b552a09af.json",
  "deckAnchorHref": "/decks/019de074-0cc8-70d5-8924-3a1b552a09af#slide-40",
  "components": [
    {
      "bbox": {
        "h": 0.2,
        "w": 0.2,
        "x": 0.76,
        "y": 0.6
      },
      "kind": "list",
      "text": "Phase 2 Progression: GEN1046 (PD-L1 x 4-1BB) - Announced data from clinical expansion cohorts and progression.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4484d4db-2ffa-42e0-bd9b-6bb00f9df95b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.22,
        "x": 0.04,
        "y": 0.2
      },
      "kind": "list",
      "text": "Geography & Indication Expansion: Sugemalimab (PD-L1) - Approved in China, EQRx targeting ex-US filings, Cstone/Pfizer announced China approval in added indication.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4b8a06c6-658d-482b-a996-bbeb87c03e82",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.22,
        "x": 0.28,
        "y": 0.2
      },
      "kind": "list",
      "text": "Recently Approved: Teclistamab (BCMA x CD3) - Clinical data published in NEJM, EU approval received ($10M milestone), FDA approval received ($25M milestone).",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8cb9a20f-5b74-45a3-8c84-0f52fd884623",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.2,
        "x": 0.76,
        "y": 0.2
      },
      "kind": "list",
      "text": "Entering Phase 2: M6223 (TIGIT) - Phase 2 trial started for Avelumab plus other agents in urothelial carcinoma.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cce395fd-e428-410a-a04c-3352981af6ab",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.22,
        "x": 0.52,
        "y": 0.2
      },
      "kind": "list",
      "text": "Additional Late-Phase Trials: Batoclimab (FcRn) - Pursuing 5 indications (Myasthenia Gravis, Thyroid Eye Disease, Chronic Inflammatory Demyelinating Polyneuropathy, Graves' Disease, Warm Autoimmune Hemolytic Anemia).",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d08c7f6d-5930-4678-bd31-2dee4321f94c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.7,
        "x": 0.04,
        "y": 0.12
      },
      "kind": "title",
      "text": "SELECT RECENT DEVELOPMENTS SHOW CONTINUED MOMENTUM AND PLATFORM VALUE",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0ed67878-f0bd-4e06-aba3-7fdf047d1a34",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.4,
        "x": 0.04,
        "y": 0.04
      },
      "kind": "title",
      "text": "Recent News Flow from Partners",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6b9cdd75-7fca-434e-8734-34577b08d76b",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}